The expanding role of somatostatin analogues in the treatment of neuroendocrine tumours: the CLARINET study

被引:8
|
作者
Kaltsas, Gregory [1 ]
Grossman, Ashley B. [2 ]
机构
[1] Natl Tech Univ Athens, Dept Pathophysiol, Athens 11527, Greece
[2] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
关键词
PROGNOSTIC-FACTORS; RECEPTOR BIOLOGY; EXPRESSION; SCINTIGRAPHY; MANAGEMENT; EVEROLIMUS; UPDATE;
D O I
10.1111/cen.12831
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:759 / 761
页数:3
相关论文
共 50 条
  • [31] Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice
    Kiesewetter, B.
    Mazal, P.
    Kretschmer-Chott, E.
    Mayerhoefer, M. E.
    Raderer, M.
    ESMO OPEN, 2022, 7 (03)
  • [32] Somatostatin Analogues in Neuroendocrine Tumors
    Kulke, Matthew H.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (03): : 241 - 242
  • [33] Relevance of somatostatin receptor expression in pancreatic neuroendocrine tumors for treatment with somatostatin analogues
    Brede, S.
    Brabant, G.
    Begum, N.
    Lehnert, H.
    Thorns, C.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [34] Role of Somatostatin Immunohistochemistry in the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Tumours
    O'Connor, R.
    Ryan, C.
    Tamagno, G.
    O'Shea, D.
    O'Toole, D.
    Geoghegan, J.
    Swan, N.
    JOURNAL OF PATHOLOGY, 2017, 243 : S39 - S39
  • [35] The Expanding Role of Somatostatin Analogs in Gastroenteropancreatic and Lung Neuroendocrine Tumors
    Cives, Mauro
    Strosberg, Jonathan
    DRUGS, 2015, 75 (08) : 847 - 858
  • [36] The Expanding Role of Somatostatin Analogs in Gastroenteropancreatic and Lung Neuroendocrine Tumors
    Mauro Cives
    Jonathan Strosberg
    Drugs, 2015, 75 : 847 - 858
  • [37] Neuroendocrine tumours (NETs) treated with somatostatin analogues: clinical responses and correlation with histological type
    Catena, Laura
    Bajetta, Emilio
    Procopio, Giuseppe
    Della Torre, Silvia
    Ferrari, Leonardo
    Martinetti, Antonia
    Bichisao, Ettore
    Buzzoni, Roberto
    ANNALS OF ONCOLOGY, 2004, 15 : 110 - 110
  • [38] Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours
    F. Forrer
    J. Mueller-Brand
    H. Maecke
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 (4) : 511 - 512
  • [39] Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues
    Chiti, A
    van Graafeiland, BJ
    Savelli, G
    Ferrari, L
    Seregni, E
    Castellani, MR
    Bombardieri, E
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 : S190 - S194
  • [40] Letter: the response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 score
    Faggiano, A.
    Carratu, A. C.
    Guadagno, E.
    Tafuto, S.
    Tatangelo, F.
    Riccardi, F.
    Mocerino, C.
    Palmieri, G.
    Damiano, V.
    Siciliano, R.
    Leo, S.
    Mauro, A.
    Tozzi, L. F.
    Battista, C.
    De Rosa, G.
    Colao, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (08) : 1033 - 1034